FGF21 is a newly discovered adipokine released from many organs, including brown adipose tissue, which is thought to prevent metabolic complications associated with obesity by increasing glucose utilization and fat oxidation in the liver [9, 36]. This evidence concerns the gene FGF21 and obesity disorder.